Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ACE-083----2件: 10, 113 💬
2Acido ascorbico----1件: 10 💬
3Ascorbic acid1件: Ascorbic acid1件: Ascorbic acid 💬 --4件: 10, 97, 206, 298 💬
4Baclofen1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬7件: 2, 10, 13, 18, 65, 149, 206 💬
5Baclofene----1件: 10 💬
6Cebion 500*20CPR mast 500MG----1件: 10 💬
7Cebion 500MG 20CPR mast.aran----1件: 10 💬
8CLZ-20021件: CLZ-2002---1件: 10 💬
9Coenzyme Q101件: Ubidecarenone1件: Ubidecarenone 💬 --12件: 2, 5, 6, 8, 10, 46, 57, 107, 113, 193, 214, 215 💬
10D-biotin----3件: 10, 13, 20 💬
11D-sorbitol1件: Sorbitol1件: Sorbitol solution 💬 --1件: 10 💬
12Elleone----1件: 10 💬
13EN001----2件: 10, 113 💬
14Engensis1件: Engensis---2件: 2, 10 💬
15Epalrestat1件: Epalrestat1件: Epalrestat 💬 1件: AKR1B 💬 5件: Folate biosynthesis, Fructose and mannose metabolism, Galactose metabolism, Glycerolipid metabolism, Pentose and glucuronate interconversions 💬1件: 10 💬
16MD1003----5件: 2, 10, 13, 14, 20 💬
17Mexiletine1件: Mexiletine2件: Mexiletine hydrochloride ,
Mexiletine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬4件: 2, 10, 113, 114 💬
18Naltrexone1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 10, 13, 96, 226 💬
19Naltrexone cloridrato1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 10 💬
20Naltrexone hydrochloride1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬9件: 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
21NMD670----3件: 3, 10, 11 💬
22NON applicable----2件: 10, 19 💬
23Posturological examination ON kplates and amti platforms----1件: 10 💬
24PXT3003----1件: 10 💬
25PXT3003 dose 1----1件: 10 💬
26PXT3003 dose 2----1件: 10 💬
27PXT3003 high dose----1件: 10 💬
28PXT3003 intermediate dose----1件: 10 💬
29PXT3003 LOW dose----1件: 10 💬
30RS-baclofen----1件: 10 💬
31Sorbitol1件: Sorbitol1件: Sorbitol solution 💬 --1件: 10 💬
32Sorbitolo----1件: 10 💬
33Ulipristal acetate1件: Ulipristal2件: Ulipristal ,
Ulipristal acetate 💬 		1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 10 💬
34Vitamin C1件: Ascorbic acid1件: Ascorbic acid 💬 --6件: 10, 192, 206, 210, 211, 212 💬